|
|
Exchange: |
Over The Counter |
Security
Type: |
Common |
Shares
Out: |
9,253,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.0055 - $0.0055 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Guided Therapeutics is a medical technology company focused on developing medical devices that have the potential to improve healthcare. Co. is primarily focused on its LuViva® Advanced Cervical Scan non-invasive cervical cancer detection device. The technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. Co. focuses on two primary applications for LuViva: as a cancer screening tool; and as a triage following conventional screening.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
500,899 |
2,100,899 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
1 |
3 |
Total Buy Transactions |
0 |
0 |
1 |
4 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Imhoff John E |
Director |
|
2015-04-08 |
4 |
A |
$0.16 |
$12,500 |
D/D |
78,125 |
9,772,337 |
|
- |
|
Hart Ronald W |
Director |
|
2015-04-08 |
4 |
S |
$0.16 |
$625 |
D/D |
(3,906) |
691,066 |
|
- |
|
Imhoff John E |
Director |
|
2015-01-16 |
4 |
A |
$0.23 |
$12,500 |
D/D |
54,348 |
9,694,212 |
|
- |
|
Hart Ronald W |
Director |
|
2015-01-16 |
4 |
S |
$0.23 |
$625 |
D/D |
(2,717) |
687,160 |
|
- |
|
Imhoff John E |
Director |
|
2014-11-26 |
4 |
B |
$0.23 |
$26,521 |
D/D |
117,870 |
9,639,864 |
3.92 |
- |
|
Cartwright Gene S |
PRESIDENT & CEO |
|
2014-11-26 |
4 |
A |
$0.23 |
$53,041 |
D/D |
235,739 |
2,335,739 |
|
- |
|
Imhoff John E |
Director |
|
2014-10-20 |
4 |
A |
$0.32 |
$12,500 |
D/D |
39,063 |
9,521,994 |
|
- |
|
Hart Ronald W |
Director |
|
2014-10-20 |
4 |
S |
$0.32 |
$625 |
D/D |
(1,953) |
1,313,154 |
|
- |
|
Imhoff John E |
Director |
|
2014-08-14 |
4 |
A |
$0.46 |
$70,000 |
D/D |
152,174 |
9,416,963 |
|
- |
|
Niloff Jonathan M |
Director |
|
2014-08-14 |
4 |
A |
$0.46 |
$70,000 |
D/D |
152,174 |
339,466 |
|
- |
|
Rosenstock Linda |
Director |
|
2014-08-14 |
4 |
A |
$0.46 |
$70,000 |
D/D |
152,174 |
287,174 |
|
- |
|
Hart Ronald W |
Director |
|
2014-08-14 |
4 |
A |
$0.46 |
$70,000 |
D/D |
152,174 |
1,311,201 |
|
- |
|
Hart Ronald W |
Director |
|
2014-07-02 |
4 |
S |
$0.50 |
$3,750 |
D/D |
(7,500) |
1,159,027 |
|
- |
|
Hart Ronald W |
Director |
|
2014-06-24 |
4 |
D |
$0.50 |
$6,250 |
D/D |
(12,500) |
1,166,527 |
|
- |
|
Cartwright Gene S |
PRESIDENT & CEO |
|
2014-06-20 |
4 |
B |
$0.49 |
$13,122 |
D/D |
27,000 |
2,100,000 |
2.81 |
- |
|
Cartwright Gene S |
PRESIDENT & CEO |
|
2014-06-19 |
4 |
B |
$0.48 |
$11,086 |
D/D |
23,000 |
2,073,000 |
2.81 |
- |
|
Cartwright Gene S |
PRESIDENT & CEO |
|
2014-06-18 |
4 |
B |
$0.49 |
$12,636 |
D/D |
26,000 |
2,050,000 |
2.81 |
- |
|
Cartwright Gene S |
Chief Executive Officer |
|
2014-06-17 |
4 |
B |
$0.49 |
$11,714 |
D/D |
24,000 |
2,024,000 |
2.81 |
- |
|
Hart Ronald W |
Director |
|
2014-06-02 |
4 |
AS |
$0.50 |
$6,250 |
D/D |
(12,500) |
1,166,527 |
|
- |
|
Hart Ronald W |
Director |
|
2014-05-29 |
4 |
AS |
$0.50 |
$6,250 |
D/D |
(12,500) |
1,179,027 |
|
- |
|
45 Records found
|
|
Page 2 of 2 |
|
|